| Structure |
Chemical Name |
CAS |
MF |
 |
Procatero Impurity |
90098-93-4 |
C11H9NO3 |
 |
4-((2-amino-3,5-dibromobenzyl)amino)cyclohexanone hydrochloride |
|
C13H17Br2ClN2O |
 |
Pazufloxacin Impurity 5 |
777824-29-0 |
C15H15FN2O2 |
 |
Vonoprazan Impurity Z-4 |
|
|
 |
Olanzapine impurity O |
|
C17H20N4S |
 |
Cabozantinib impurity 26 |
2840522-80-5 |
C28H25ClFN3O5 |
 |
Dapoxetine impurity 24 |
1445281-20-8 |
C20H20O4S |
 |
Tazobactam Impurity E |
|
|
 |
Vildagliptin Impurity 42 |
|
|
 |
Canagliflozin Impurity 45 |
|
|
 |
5-chloro-3-sulfo-2-Thiophenecarboxylic acid |
187746-94-7 |
C5H3ClO5S2 |
 |
Pralatrexate Impurity 5 |
|
|
 |
3,3'-diMethyl-1,1'-diphenyl-1H,1'H-4,4'-bipyrazole-5,5'-diol |
177415-76-8 |
C20H18N4O2 |
 |
Pitavastatin Impurity 61 |
|
|
![5-(2-cyclopropyl-1-(3-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate](/CAS/20150408/GIF/1391194-39-0.gif) |
5-(2-cyclopropyl-1-(3-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate |
1391194-39-0 |
C20H20FNO3S |
 |
Sitafloxacin Impurity 17 |
|
|
 |
(S)-N-(1-(3-MethylbutanaMido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide |
862894-96-0 |
C19H22N4O3 |
 |
Cilastatin Isomer Impurity |
|
|
 |
Prednicarbate Impurity E |
|
|
 |
Olprinone Impurity B |
|
|
 |
Canagliflozin Impurity 51 |
|
|
 |
Canagliflozin Impurity 67 |
|
|
 |
Cefazolin Impurity Q |
|
|
 |
Cabozantinib impurity M |
|
|
 |
Rotigotine Impurity 8 |
|
|
 |
Palbociclib-025 |
2174002-16-3 |
C25H29N7O3 |
 |
Nitrendipine iMpurity 3 |
|
|
 |
Cefminox Impurity 3 |
|
|
 |
Bosutinib Impurity 15 |
|
|
 |
Ertapenem Impurity 2 |
|
|
 |
Febuxostat Impurity 68 |
|
|
 |
Indacaterol Impurity 9 |
|
|
 |
Olanzapine Impurity 22 |
|
C17H20N4S |
 |
Olopatadine Impurity 9 |
680579-52-6 |
C39H36Br2P2 |
 |
Oseltamivir Impurity 59 |
2485836-60-8 |
C12H22N2O3 |
 |
Palbociclib Impurity 36 |
|
|
 |
Regorafenib Impurity 34 |
|
|
 |
Ticagrelor iMpurity |
1882095-51-3 |
C27H45N5O8S |
 |
cefaclor iMpurity G |
67308-21-8 |
C16H17N3O4S |
 |
Rupatadine iMpurity E |
|
|
 |
Tadalafil iMpurity D |
951661-81-7 |
C22H20ClN3O4 |
![2-Thiopheneacetic acid, α-hydroxy-α-2-thienyl-, (3R)-1-azabicyclo[2.2.2]oct-3-yl ester](/CAS/20150408/GIF/320347-97-5.gif) |
2-Thiopheneacetic acid, α-hydroxy-α-2-thienyl-, (3R)-1-azabicyclo[2.2.2]oct-3-yl ester |
320347-97-5 |
C17H19NO3S2 |
 |
benzbroMarone iMpurity |
|
|
 |
Dasatinib iMpurity |
1184919-23-0 |
C22H27N7O2S |
 |
eszopiclone iMpurity |
|
|
 |
IMidafenacin iMpurity |
503599-41-5 |
C18H20N2O2 |
 |
latanoprost iMpurity |
733036-95-8 |
C25H35FO5 |
 |
Irbesartan IMpurity D |
|
C25H28N6O |
 |
1,2,3,9-テトラヒドロ-3-(1H-イミダゾール-1-イルメチル)-9-メチル-4H-カルバゾール-4-オン (ONDANSETRON IMPオンダンセトロン不純物G |
99614-03-6 |
C17H17N3O |
 |
lithiuM 2-(4-(Methylsulfonyl)phenyl)acetate |
1421227-96-4 |
C9H11LiO4S |
 |
Ceftriaxone IMpurit C |
|
|
 |
Flucloxacillin IMpurity G |
|
|
 |
Gefitinib N-Oxide |
847949-51-3 |
C22H24ClFN4O4 |
 |
Milrinone IMpurity 3 |
98293-81-3 |
C12H7N3O3 |
 |
Rosuvastatin Impurity 47 |
|
|
 |
Sildenafil Impurity 36 |
|
C25H27N3O5 |
![(1R)-1-[(3,4-ジメトキシフェニル)メチル]-6,7-ジメトキシ-2-メチル-1,2,3,4-テトラヒドロイソキノリン](/CAS/20200331/GIF/85-63-2.gif) |
(1R)-1-[(3,4-ジメトキシフェニル)メチル]-6,7-ジメトキシ-2-メチル-1,2,3,4-テトラヒドロイソキノリン |
85-63-2 |
C21H27NO4 |
 |
Linagliptin Impurity P |
|
|
 |
Linagliptin Impurity U |
|
|
 |
(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzoic acid |
1917324-15-2 |
C18H21FN4O4 |
 |
N1,N4-bis((R)-1-(3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)succinamide |
|
C40H42F2N10O6 |
![ethyl ((1R,3aR,4aR,6S,8aR,9S,9aS)-9-((E)-2-(5-(3-fluorophenyl)pyridin-2-yl)vinyl)-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-yl)carbamate](/CAS/20180703/GIF/618385-10-7.gif) |
ethyl ((1R,3aR,4aR,6S,8aR,9S,9aS)-9-((E)-2-(5-(3-fluorophenyl)pyridin-2-yl)vinyl)-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-yl)carbamate |
618385-10-7 |
C29H33FN2O4 |
 |
(2R)-2-deoxy-2-fluoro-2-methyl-α/β-D-erythro-pentofuranosyl chloride-3,5-dibenzoate |
1621160-31-3 |
C20H18ClFO5 |
 |
Etoricoxib Impurity 17 |
|
|
 |
Ibrutinib Impurity 3 |
1226872-27-0 |
C25H26N6O4 |
 |
Posaconazole Impurity 30 |
|
|
 |
Posaconazole Impurity 35 |
1370190-85-4 |
C14H13F2N3O |
 |
Posaconazole Impurity 51 |
357189-94-7 |
C37H40F2N8O5 |
 |
Posaconazole Impurity 59 |
|
|
 |
Ramosetron Impurity 13 |
183613-77-6 |
C17H13N3O |
 |
Sitafloxacin Impurity 2 |
|
C23H10Cl2F4N2O6 |
 |
Sitagliptin Impurity 10 |
1253056-01-7 |
C16H14F6N4O2 |
 |
SofosBuvir Impurity 18 |
|
|
 |
sofosBuvir Impurity 35 |
|
|
 |
SofosBuvir Impurity 51 |
|
|
 |
SofosBuvir Impurity 58 |
|
|
 |
Sulbactam EP Impurity G |
|
|
 |
Ticagrelor impurity 21 |
|
|
 |
Tirofiban Impurity 13 |
|
C27H45N3O3 |
 |
Tofacitinib impurity U |
|
|
 |
Vortioxetine impurity S |
1815608-51-5 |
C18H22N2S |
 |
Linagliptin N-Acetyl Impurity |
1803079-49-3 |
C27H30N8O3 |
![(1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid](/CAS/20180601/GIF/474668-76-3.gif) |
(1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid |
474668-76-3 |
C19H16N2O4 |
 |
Lidocaine Impurity |
70336-49-1 |
C20H22N2O2 |
 |
E-テリフルノミド |
214782-56-6 |
C12H9F3N2O2 |
 |
Ampicillin Impurity R |
|
|
 |
Spectinomycin Impurity C |
|
|
 |
Amifostine Impurity 2 |
|
|
 |
Brexpiprazole Impurity |
2138169-93-2 |
C41H47N5O2S2 |
 |
Cefoxitin impurity EF |
|
|
 |
Tenofovir Impurity 38 |
161760-09-4 |
C8H11O6PS |
 |
N-(4-methyl-3-(3-(4-((4-methylpiperazin-1-yl)methyl)benzoyl)guanidino)phenyl)-4-(4-methylpiperazin-1-yl)benzamide |
|
C33H42N8O2 |
 |
XMUJPIDSOJTMMS-VTBMCCKRSA-N |
212505-49-2 |
C21H30O3 |
 |
XLMHAABXFLIUNQ-UHFFFAOYSA-N |
368451-15-4 |
C24H26O3 |
 |
クロルフェニラミンN-オキシド DIHYDROCHLORIDE |
120244-82-8 |
C16H19ClN2O |
 |
4-メチル-1-ピペラジンカルボニルクロリド |
39539-66-7 |
C6H11ClN2O |
 |
Empagliflozin Impurity POE |
|
|
 |
Febuxostat Impurity 73 |
|
|
 |
Nicardipine Related CoMpound 4 |
123973-71-7 |
C25H27N3O6 |
 |
PraMipexole IMp.BI-II786BS |
|
|